{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:35:43Z","timestamp":1789011343752,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.contraception.2010.02.016","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T04:37:55Z","timestamp":1270096675000},"page":"147-154","source":"Crossref","is-referenced-by-count":46,"title":["Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels"],"prefix":"10.1016","volume":"82","author":[{"given":"Rodolfo","family":"Strufaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano M.","family":"Pompei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everaldo P.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar E.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.02.016_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0306-4530(93)90060-X","article-title":"Sex steroids, sexual behavior and selection attention for erotic stimuli in women using oral contraceptives","volume":"18","author":"Alexander","year":"1993","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2010.02.016_bib2","series-title":"The Cochrane Library, Issue 1","article-title":"Testosterone for peri- and postmenopausal women (Cochrane Review)","author":"Somboonporn","year":"2009"},{"key":"10.1016\/j.contraception.2010.02.016_bib3","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/j.1743-6109.2008.00992.x","article-title":"Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones","volume":"5","author":"Stuckey","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2010.02.016_bib4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/deh686","article-title":"Effects of two types of hormonal contraception \u2014 oral versus intravaginal \u2014 on the sexual life of women and their partners","volume":"20","author":"Guida","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.02.016_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13625180701712406","article-title":"Evaluation of the quality of life and sexual functioning of women using a 30-microg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive","volume":"13","author":"Skrzypulec","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.02.016_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.psyneuen.2006.12.011","article-title":"Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?","volume":"32","author":"Graham","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2010.02.016_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2007.04.002","article-title":"The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol","volume":"76","author":"Greco","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2004.06.010","article-title":"Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women","volume":"70","author":"Li","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s10508-007-9287-8","article-title":"Evaluation of the female sexual function index in a population based sample from Finland","volume":"37","author":"Witting","year":"2008","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.contraception.2010.02.016_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2003.11.001","article-title":"Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol\/60 microg gestodene","volume":"69","author":"Caruso","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.ijir.3900655","article-title":"Decreased circulating levels of estrogen alter vaginal and clitorial blood flow and structure in the rabbit","volume":"13","author":"Park","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.contraception.2010.02.016_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0094-0143(05)70148-8","article-title":"Female sexual dysfunction","volume":"28","author":"Berman","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.contraception.2010.02.016_bib13","series-title":"Medical Eligibility Criteria for Contraceptive Use. 2008 Update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.contraception.2010.02.016_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.contraception.2010.02.016_bib15","first-page":"10","article-title":"Valida\u00e7\u00e3o do Female Sexual Function Index (FSFI) para uso em l\u00edngua portuguesa","volume":"27","author":"Hentschel","year":"2007","journal-title":"Rev HCPA"},{"key":"10.1016\/j.contraception.2010.02.016_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.gme.0000177709.65944.b0","article-title":"The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society","volume":"12","author":"Shifren","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2010.02.016_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0197-2456(98)00037-3","article-title":"Power and sample size calculations for studies involving linear regression","volume":"19","author":"Dupont","year":"1998","journal-title":"Control Clin Trials"},{"issue":"1A","key":"10.1016\/j.contraception.2010.02.016_bib18","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am J Med."},{"key":"10.1016\/j.contraception.2010.02.016_bib19","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: an Endocrine Society Clinical Practice guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.02.016_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.contraception.2007.11.009","article-title":"Self-described impact of noncompliance among users of a combined hormonal contraceptive method","volume":"77","author":"Lete","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"Moreau","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e318185e249","article-title":"Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation","volume":"16","author":"Torr\u00e9ns","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2010.02.016_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/eje.1.02065","article-title":"Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study","volume":"154","author":"Le\u00e3o","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.contraception.2010.02.016_bib26","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/humrep\/dep209","article-title":"Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging","volume":"24","author":"Sowers","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.02.016_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2265.2007.03053.x","article-title":"Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia","volume":"68","author":"Cho","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2010.02.016_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.contraception.2008.08.011","article-title":"The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters","volume":"79","author":"Winkler","year":"2009","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2010.02.016_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2008.10.010","article-title":"Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol\/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol\/2 mg cyproterone acetate","volume":"79","author":"Palombo-Kinne","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.02.016_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2006-924062","article-title":"Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone","volume":"114","author":"Mueller","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T08:16:53Z","timestamp":1635149813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0010782410000600"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.02.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}